Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 17, Issue 12, Pages 1107-1116
Publisher
Informa UK Limited
Online
2017-10-09
DOI
10.1080/14737140.2017.1390431
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels
- (2017) Paolo G. Casali et al. JOURNAL OF CLINICAL ONCOLOGY
- A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control
- (2017) Kamran Harati et al. World Journal of Surgical Oncology
- Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial
- (2016) Peter Reichardt et al. BMC CANCER
- Diagnostic and treatment strategy for small gastrointestinal stromal tumors
- (2016) Toshirou Nishida et al. CANCER
- Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies
- (2016) Kjetil Søreide et al. Cancer Epidemiology
- Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group
- (2016) Anna Patrikidou et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial
- (2016) Heikki Joensuu et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Gastrointestinal Stromal Tumors
- (2016) Margaret von Mehren SURGICAL CLINICS OF NORTH AMERICA
- Combined Therapy of Gastrointestinal Stromal Tumors
- (2016) Piotr Rutkowski et al. Surgical Oncology Clinics of North America
- Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment-use trial of sunitinib
- (2015) Peter Reichardt et al. CANCER
- Current treatment options for dermatofibrosarcoma protuberans
- (2015) Piotr Rutkowski et al. Expert Review of Anticancer Therapy
- CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans
- (2015) G. Eilers et al. MOLECULAR CANCER THERAPEUTICS
- Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST
- (2014) A. Wozniak et al. CLINICAL CANCER RESEARCH
- Quadruplewild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways
- (2014) Maria A. Pantaleo et al. Cancer Medicine
- Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor
- (2013) Ronald P. DeMatteo et al. ANNALS OF SURGERY
- Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience
- (2013) Piotr Rutkowski et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant Imatinib in Advanced Primary or Locally Recurrent Dermatofibrosarcoma Protuberans: A Multicenter Phase II DeCOG Trial with Long-term Follow-up
- (2013) S. Ugurel et al. CLINICAL CANCER RESEARCH
- Dermatofibrosarcoma Protuberans: Long-term Outcomes of 53 Patients Treated With Conservative Surgery and Radiation Therapy
- (2013) Katherine O. Castle et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
- (2013) Piotr Rutkowski et al. MEDICAL ONCOLOGY
- Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib
- (2012) R. Tielen et al. EJSO
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor
- (2012) Heikki Joensuu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) George D Demetri et al. LANCET
- Natural History of Imatinib-naive GISTs
- (2011) Sabrina Rossi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
- (2011) Dian Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors
- (2011) Piotr Rutkowski et al. CANCER
- Spectrum of KIT/PDGFRA/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST)
- (2011) Marc Daniels et al. CANCER LETTERS
- Dermatofibrosarcoma protuberans (DFSP): Predictors of Recurrence and the Use of Systemic Therapy
- (2010) Ryan C. Fields et al. ANNALS OF SURGICAL ONCOLOGY
- Imatinib Mesylate as a Preoperative Therapy in Dermatofibrosarcoma: Results of a Multicenter Phase II Study on 25 Patients
- (2010) D. Kerob et al. CLINICAL CANCER RESEARCH
- Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
- (2010) Piotr Rutkowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection
- (2010) P Rutkowski et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial
- (2010) Axel Le Cesne et al. LANCET ONCOLOGY
- Current treatment options in dermatofibrosarcoma protuberans
- (2009) Doreen Lemm et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors
- (2008) N. P. Agaram et al. CLINICAL CANCER RESEARCH
- Clinical significance of oncogenicKITandPDGFRAmutations in gastrointestinal stromal tumours
- (2008) J Lasota et al. HISTOPATHOLOGY
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastrointestinal stromal tumours (GIST) – 17 years experience from Mid Trent Region (United Kingdom)
- (2007) I. Ahmed et al. EJSO
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started